Cargando…
LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma
OBJECTIVE: LRPPRC is a newly discovered N(6)-methyladenosine (m(6)A) modification reader, which potentially affects hepatocellular carcinoma (HCC) progression. PD-L1 in tumor cells is essential for tumor immune evasion. This work investigated the LRPPRC-mediated m(6)A-modification effect on PD-L1 mR...
Autores principales: | Wang, Houhong, Tang, Amao, Cui, Yayun, Gong, Huihui, Li, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097877/ https://www.ncbi.nlm.nih.gov/pubmed/37063837 http://dx.doi.org/10.3389/fimmu.2023.1144774 |
Ejemplares similares
-
Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023) -
Suppression of AGTR1 Induces Cellular Senescence in Hepatocellular Carcinoma Through Inactivating ERK Signaling
por: Wang, Houhong, et al.
Publicado: (2022) -
LRPPRC/SLIRP suppresses PNPase-mediated mRNA decay and promotes polyadenylation in human mitochondria
por: Chujo, Takeshi, et al.
Publicado: (2012) -
Drosophila protease ClpXP specifically degrades DmLRPPRC1 controlling mitochondrial mRNA and translation
por: Matsushima, Yuichi, et al.
Publicado: (2017) -
Upregulation of LRRC8A by m(5)C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer
por: Chen, Yanjie, et al.
Publicado: (2023)